These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2680435)

  • 21. S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis.
    Guo T; Chang L; Xiao Y; Liu Q
    PLoS One; 2015; 10(3):e0122124. PubMed ID: 25774783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of methionine in liver disease.
    Mato JM; Ortiz P
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():35-46. PubMed ID: 8899692
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic effects and mechanism of action of S-adenosyl-L-methionine (SAM) in depressive syndromes].
    Fazio C; Andreoli V; Agnoli A; Casacchia M; Cerbo R
    Minerva Med; 1973 Apr; 64(29):1515-29. PubMed ID: 4576704
    [No Abstract]   [Full Text] [Related]  

  • 24. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results.
    Ribalta J; Reyes H; Gonzalez MC; Iglesias J; Arrese M; Poniachik J; Molina C; Segovia N
    Hepatology; 1991 Jun; 13(6):1084-9. PubMed ID: 2050326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule.
    Bottiglieri T
    Am J Clin Nutr; 2002 Nov; 76(5):1151S-7S. PubMed ID: 12418493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [S-adenosyl L-methionine in CNS diseases].
    Krzystanek M; Pałasz A; Krzystanek E; Krupka-Matuszczyk I; Wiaderkiewicz R; Skowronek R
    Psychiatr Pol; 2011; 45(6):923-31. PubMed ID: 22335134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of S-adenosyl-L-methionine on liver damage in experimental obstructive jaundice.
    Tsai SM; Lee KT; Tsai LY
    Kaohsiung J Med Sci; 2001 Sep; 17(9):455-60. PubMed ID: 11842648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
    Pancheri P; Scapicchio P; Chiaie RD
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):287-94. PubMed ID: 12466028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of adenosyl-methionine in alcoholic liver disease and intrahepatic cholestasis.
    Testino G; Leone S; Fagoonee S; Pellicano R
    Minerva Gastroenterol Dietol; 2018 Sep; 64(3):187-189. PubMed ID: 29521488
    [No Abstract]   [Full Text] [Related]  

  • 30. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism.
    Stramentinoli G; Di Padova C; Gualano M; Rovagnati P; Galli-Kienle M
    Gastroenterology; 1981 Jan; 80(1):154-8. PubMed ID: 7450400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [S-adenosylmethionine as a regulator of protein synthesis. Influence on plasmatic fibrinogen].
    Frezza M; Pozzato G; Valente G; Gilotta S; Milani S; Nicolini R
    Minerva Med; 1977 Apr; 68(17):1105-14. PubMed ID: 857203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease.
    Vendemiale G; Altomare E; Trizio T; Le Grazie C; Di Padova C; Salerno MT; Carrieri V; Albano O
    Scand J Gastroenterol; 1989 May; 24(4):407-15. PubMed ID: 2781235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009; 70 Suppl 5():18-22. PubMed ID: 19909689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis.
    Almasio P; Bortolini M; Pagliaro L; Coltorti M
    Drugs; 1990; 40 Suppl 3():111-23. PubMed ID: 2081476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuropsychiatric disorders and transmethylation: therapeutic effects of S-adenosyl-L-methionine].
    Agnoli A; Fazio C; Andreoli V; De Carolis V; Bonamini F; Pastorino P; Casacchia M; Cerbo R; Ruggieri S; Carolei A
    Clin Ter; 1975 Dec; 75(6):567-79. PubMed ID: 767041
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of S-adenosyl-L-methionine in liver health and injury.
    Mato JM; Lu SC
    Hepatology; 2007 May; 45(5):1306-12. PubMed ID: 17464973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis.
    Coltorti M; Bortolini M; Di Padova C
    Methods Find Exp Clin Pharmacol; 1990; 12(1):69-78. PubMed ID: 2179653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies.
    Delle Chiaie R; Pancheri P; Scapicchio P
    Am J Clin Nutr; 2002 Nov; 76(5):1172S-6S. PubMed ID: 12418499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.
    Hardy ML; Coulter I; Morton SC; Favreau J; Venuturupalli S; Chiappelli F; Rossi F; Orshansky G; Jungvig LK; Roth EA; Suttorp MJ; Shekelle P
    Evid Rep Technol Assess (Summ); 2003 Aug; (64):1-3. PubMed ID: 12899148
    [No Abstract]   [Full Text] [Related]  

  • 40. The action of S-adenosyl-L-methionine on the levels of triglyceride and phospholipid precursors in ethanol-intoxicated rat liver.
    Palmerini CA; Corazzi L; Arienti G
    Farmaco Sci; 1981 Nov; 36(11):942-6. PubMed ID: 7198060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.